ACTIVE

KELA - Kempisch Laboratorium - Kela Laboratoria

Financial year 2025 · closed on 31/12/2025
Net result
-1,2 M €
-105.0% YoY
Revenue
55,2 M €
+8.9% YoY
Equity
31,9 M €
-3.6% YoY
Workforce
261,4 ETP
+3.0% YoY

What does KELA - Kempisch Laboratorium - Kela Laboratoria do?

KELA - Kempisch Laboratorium - Kela Laboratoria is a Public limited company incorporated in 1941. Its registered office is in Hoogstraten. It employs on average 261,4 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0403.835.645
Incorporation
15/07/1941
Legal form
Public limited company
Registered office
Sint Lenaartseweg 48
2320 Hoogstraten · FlandreSee on map
Contributed capital
8 927 302,00 €
Latest accounts
31/12/2025
Average workforce
261,4 ETP
Joint committees (2)
  • 116
  • 207
Signals
Solid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 19 financial years

2025202420232022202120202019201820172016201520142013201220112010200920072006
Income statement
Revenue55,2 M €50,7 M €47 M €47,2 M €48,8 M €47,8 M €43,2 M €40,4 M €41,5 M €41,4 M €40,9 M €39,7 M €36,5 M €33,9 M €32 M €29,8 M €28,7 M €29,5 M €25,3 M €
EBITDA1,8 M €4,3 M €1,1 M €-177,5 k €4,3 M €1,9 M €2,7 M €2,8 M €2,5 M €1,6 M €3,2 M €3,6 M €3,7 M €3,5 M €5,2 M €4,7 M €3,4 M €4,6 M €3,7 M €
Operating result-746,4 k €2,3 M €-1,1 M €-2,1 M €2,3 M €342,7 k €752,4 k €1,3 M €480,4 k €-196 k €845,5 k €1,6 M €1,3 M €871,5 k €2,3 M €1,8 M €218,9 k €1,5 M €1 M €
Net result-1,2 M €23,8 M €-2,2 M €-575,7 k €1,2 M €848,3 k €27 k €376,6 k €61,9 k €70,4 k €405,9 k €585 k €343 k €199,2 k €663,4 k €1,1 M €-676,3 k €325,6 k €449 k €
Balance sheet
Equity31,9 M €33,1 M €9,7 M €12 M €12,8 M €11,6 M €10,8 M €10,7 M €10,4 M €10,3 M €10,2 M €10,2 M €10 M €10 M €10 M €9,9 M €9,4 M €7,6 M €7,6 M €
Total assets63,2 M €62,4 M €53,7 M €51,8 M €49,8 M €47,7 M €45,3 M €42,1 M €40,7 M €39,2 M €35,5 M €33,5 M €31 M €29,2 M €31,4 M €31,3 M €32,6 M €34,9 M €34,7 M €
Cash1,4 M €7,9 M €2,1 M €957,6 k €1,7 M €1 M €822,4 k €2,7 M €805,1 k €1,2 M €3,6 M €1,8 M €1,6 M €1 M €327,8 k €384,6 k €991,8 k €790,2 k €452,5 k €
Debts30,6 M €28,7 M €43,6 M €39,5 M €36,9 M €36 M €34,5 M €31,1 M €30,1 M €28,4 M €25 M €23 M €20,6 M €19,1 M €21,3 M €21,3 M €23 M €27,2 M €27 M €
Other
Workforce261,4 ETP253,8 ETP252,3 ETP245,6 ETP247,8 ETP232,6 ETP198,3 ETP182,1 ETP179,5 ETP169,4 ETP164,9 ETP156,4 ETP147,9 ETP138,1 ETP137,9 ETP137,9 ETP147,0 ETP148,4 ETP148,5 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 35 ended

Active mandates

VOXDALE

Director · since 19 décembre 2023 · 0435.552.467

Represented by Pascal BEYENS

Active

Ended mandates

VOXDALE

Director · since 19 décembre 2023 · 0435.552.467

Represented by René BEYERS

Ended
Renatus BEYERS

Director · since 24 juin 2022 · until 19 décembre 2023

Ended
Renatus BEYERS

Director · since 24 juin 2022 · until 23 juin 2028

Ended
Philomena Van Pelt

Director · since 14 mai 2019 · until 13 mai 2025

Ended
At this address

Other companies at this address

CompanyCBE no.
0412.402.527
MedicemActive
0418.885.986
PHENIX PROPERTYActive
0413.676.987
VOXDALEActive
0435.552.467
Annual accounts

Full financial information

202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date01/07/202630/06/202503/07/202419/07/202320/07/202219/07/2021
General meeting02/06/202624/06/202504/06/202420/06/202324/06/202225/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

31 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202502/06/202601/07/2026DutchPDF
Full model31/12/202424/06/202530/06/2025DutchPDF
Full model31/12/202304/06/202403/07/2024DutchPDF
Full model31/12/202220/06/202319/07/2023DutchPDF
Full model31/12/202124/06/202220/07/2022DutchPDF
Full model31/12/202025/06/202119/07/2021DutchPDF
Full model31/12/201929/06/202002/07/2020DutchPDF
Full model31/12/201814/05/201904/07/2019DutchPDF
Full model31/12/201708/05/201808/06/2018DutchPDF
Full model31/12/201609/05/201701/06/2017DutchPDF
Consolidated accounts31/12/201609/05/201727/06/2017DutchPDF
Full model31/12/201517/05/201623/06/2016DutchPDF
Consolidated accounts31/12/201517/05/201617/06/2016DutchPDF
Full model31/12/201412/05/201524/06/2015DutchPDF
Consolidated accounts31/12/201412/05/201503/07/2015DutchPDF
Full model31/12/201313/05/201404/06/2014DutchPDF
Consolidated accounts31/12/201313/05/201418/06/2014DutchPDF
Full model31/12/201214/05/201316/05/2013DutchPDF
Consolidated accounts31/12/201214/05/201311/06/2013DutchPDF
Full model31/12/201108/05/201201/06/2012DutchPDF
Consolidated accounts31/12/201129/05/201228/06/2012DutchPDF
Full model31/12/201010/05/201127/05/2011DutchPDF
Consolidated accounts31/12/201010/05/201120/05/2011DutchPDF
Full model31/12/200911/05/201020/05/2010DutchPDF

View all 31 filings

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 35 ended

Active mandates

VOXDALE

Director · since 19 décembre 2023 · 0435.552.467

Represented by Pascal BEYENS

Active

Ended mandates

VOXDALE

Director · since 19 décembre 2023 · 0435.552.467

Represented by René BEYERS

Ended
Renatus BEYERS

Director · since 24 juin 2022 · until 19 décembre 2023

Ended
Renatus BEYERS

Director · since 24 juin 2022 · until 23 juin 2028

Ended
Philomena Van Pelt

Director · since 14 mai 2019 · until 13 mai 2025

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates03/01/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates14/05/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates11/01/2024
    DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates19/05/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates20/11/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates25/09/2018
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates14/11/2017
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates13/02/2017
    ONTSLAGEN - BENOEMINGEN
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-1,2 M €
  2. 2024
    Annual accounts 202423,8 M €
  3. 24/10/2024
    nominationPascal Beyens — vast vertegenwoordiger
  4. 2023
    Annual accounts 2023-2,2 M €
  5. 2022
    Annual accounts 2022-575,7 k €
  6. 24/06/2022
    reconductionRenatus Beyers — bestuurder
  7. 24/06/2022
    nominationArnaud Clybouw — commissaris
  8. 2021
    Annual accounts 20211,2 M €
  9. 2021
    Name changeKEMPISCH LABORATORIUM
  10. 2020
    Annual accounts 2020848,3 k €
  11. 2019
    Annual accounts 201927 k €
  12. 2018
    Annual accounts 2018376,6 k €
  13. 2017
    Annual accounts 201761,9 k €
  14. 2016
    Annual accounts 201670,4 k €
  15. 2015
    Annual accounts 2015405,9 k €
  16. 2014
    Annual accounts 2014585 k €
  17. 2013
    Annual accounts 2013343 k €
  18. 2012
    Annual accounts 2012199,2 k €
  19. 2011
    Annual accounts 2011663,4 k €
  20. 2010
    Annual accounts 20101,1 M €
  21. 2009
    Annual accounts 2009-676,3 k €
  22. 2007
    Annual accounts 2007325,6 k €
  23. 2006
    Annual accounts 2006449 k €
  24. 2006
    Name changeKELA - Kempisch Laboratorium - Kela Laboratoria
  25. 15/07/1941
    IncorporationPublic limited company